Drugs / SYNCAR-100
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07429461 | Feb 2026 → Dec 2027 expected | B-cell acute lymphoblastic leukemia | Zhejiang University | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SYNCAR-100 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07429461 ↗ |
| Modality | Other / unclassified | “based on circular RNA (circRNA) technology.” NCT07429461 ↗ |
| Route | Intravenous | “Subjects will receive intravenous injections once weekly for a total of 4 injections.” NCT07429461 ↗ |